Allogeneic stem-cell transplant recipients face increased risk of CV disease TheHeart.Org Duarte, CA - Hematopoietic cell transplants (HCT) offer a cure for hematological malignancies, but undergoing the procedure puts long-term survivors at increased risk of cardiovascular disease, according to a new study published online October 3, 2012 ... |
